×
Home
Medical Cannabis
DanCann Pharma
Research decides – but – Patients inspires
Vision and Mission
Seed-to-sale
Vertical Aeroponic Cultivation
Active Pharmaceutical Ingredients
Intermediate Manufacturing
Research and Development
Handling of Import and Sourcing
Board of Directors
Executive Management
Investor Relations (IR)
Introduction
Share information
Press Releases
Initial Public Offering (IPO)
Major Shareholders
General Meetings
Corporate Governance
Financial Calendar
Financial Reports
IR-Contact
Board of Directors
Executive Management
Contact
Home
Medical Cannabis
DanCann Pharma
Investor Relations (IR)
Contact
Scroll to see more
General meetings/
historic events
Minutes of extraordinary general meeting dated 21 September 2020 (pdf)
Minutes of extraordinary general meeting dated 6 July 2020 (pdf)
Minutes of extraordinary general meeting dated 26 June 2020 (pdf)
Minutes of extraordinary general meeting dated 8 April 2020 (pdf)
DanCann Pharma, Annual Report 2020
DanCann Pharma, AGM 280421 Notice of AGM 2021
DanCann Pharma, AGM 280421 Form (vote - proxy - admission)
DanCann Pharma, Schedule 1_Annual Report 2020
DanCann Pharma, Schedule 2_Board members for election
DanCann Pharma, Schedule 3_Draft of Articles of Association DanCann Pharma (mark-up)
DanCann Pharma, Schedule 4_ Schedule 6.3 - Warrants for board members
×